The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

Not Applicable

Terminated

• Conditions: Diabetes Mellitus

• Registration Number: NCT00280085
• Lead Sponsor: Pfizer

Brief Summary

Assess pancreatic beta cell function using MR imaging.

Detailed Description

The study was terminated on July 31st, 2007. The study was discontinued, as we have not met the primary end point, differentiation between normal volunteers and subjects with type 1 diabetes mellitus. There were no safety concerns.

Study Timeline

• Study Start: 2005-12
• Study First Submitted: 2006-01-18
• Study First Submitted QC: 2006-01-18
• Study First Posted: 2006-01-20
• Study Completion: 2007-07
• Status Verified: 2008-09
• Last Update Submitted: 2009-08-06
• Last Update Posted: 2009-08-07

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

• Normal Volunteers
• T1DM and T2DM subjects

Exclusion Criteria

• Concomitant severe conditions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Pancreatic perfusion

Trial Locations

Locations (1)

Pfizer Investigational Site; 🇺🇸 New Haven, Connecticut, United States